Archives: Press

Neucore Bio Awarded Competitive Grant from the U.S. National Science Foundation for Research on Scalability of Exosome-based Therapeutics for Genetic Disease
Clarametyx Biosciences Announces FDA Grant Of Fast Track And Qualified Infectious Disease Product Designations For CMTX-101
Kristy Campbell is driven to help startups
Clarametyx Biosciences Announces Positive Interim Analysis in Phase 2a Study Evaluating CMTX-101 for Infections Associated with Cystic Fibrosis
50 Columbus-Based Startups on Display at Annual Innovation Hop
Rev1’s Innovation Hop: Bold startups. Big ideas. One night only.
CincyTech Invests in Clarametyx to Advance Breakthrough Anti-Biofilm Therapies for Chronic Respiratory Disease
HealthPlan Data Solutions Secures $15M with MK Capital to Accelerate Innovation in Pharmacy Benefit Payment Integrity
71/70 Angels launches first fund to expand Ohio’s angel investor network
1 2 3 106